Company: SPEG
Filing Date: 2025-07-15
Form Type: 424B4
Source: 0001213900-25-064326
Chunk: 100

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-07-15
Form: 424B4
Chunk 100
---
 advantageous to our public shareholders as they would be absent any conflicts of interest. Since our sponsor, officers and directors, and any other holders of our founder shares, including any non-managing sponsor investors, may lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. In June 2024, our sponsor paid $25,000, or approximately $0.006 per share, to cover certain of our offering costs in exchange for 4,312,500 Class B ordinary shares or founder shares. Subsequently, on February6, 2025, the Company, through a share capitalization, issued the sponsor an additional 1,437,500 Class B ordinary shares as bonus shares, bringing the aggregate number of founder shares to 5,750,000 Class B ordinary shares, resulting in a price per share of approximately $0.004. On May7, 2025, the sponsor surrendered 1,916,667shares leaving 3,833,333 resulting in a price per share of $0.0075. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no assets, tangible or intangible. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 11,500,000 units if the underwriters’ over -allotmentoption is exercised in full, and therefore that such founder shares would represent 25% of the outstanding shares after this offering. Up to 500,000 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised. The founder shares will be worthless if we do not complete an initial business combination, except to the extent they receive liquidating distributions from assets outside of the trust account. In addition, our sponsor and Roth, the representative of the underwriters, have committed to purchase an aggregate of 3,250,000 private placement warrants (whether or not the underwriters’ over -allotmentoption is exercised) for an aggregate purchase price of $3,250,000, or $1.00 per private placement warrant. Of those